Hematological immune related adverse events after treatment with immune checkpoint inhibitors
European Journal of Cancer2021Vol. 147, pp. 170–181
Citations Over TimeTop 10% of 2021 papers
Rafaela Kramer, Anne Zaremba, Alvaro Moreira, Selma Ugurel, Douglas B. Johnson, Jessica C. Hassel, Martin Salzmann, Anja Gesierich, Alison M. Weppler, Lavinia Spain, Carmen Loquai, Milena Dudda, Claudia Pföhler, Adriana Hepner, Georgina V. Long, Alexander M. Menzies, Matteo S. Carlino, Michael Sachse, Célèste Lebbé, Barouyr Baroudjian, Tomohiro Enokida, Makoto Tahara, Max Schlaak, Kinan Hayani, Paul J. Bröckelmann, Friedegund Meier, Lydia Reinhardt, Philip Friedlander, Thomas Eigentler, Katharina C. Kähler, Carola Berking, Lisa Zimmer, Lucie Heinzerling
Related Papers
- → Immunosuppression after pediatric liver transplant: The parents’ perspective(2023)3 cited
- → General Principle of Immunosuppression(2013)
- Hemophagocytic Lymphohistiocytosis (HLH) in adults: Results of the German HLH registry(2015)
- → A Hematopathology Case Study of Familial Hemophagocytic Lymphohistiocytosis (HLH)(2022)